Browsing: weightloss

Most weight-loss drugs do not meaningfully improve quality of life and few show improvements to heart health after a year, a new analysis has found

Dr. Jang Hyung-woo, a cardiothoracic surgery professor at Bundang Seoul National University Hospital, shares his experience losing 40 kilograms using Wegovy and Mounjaro during a Tuesday appearance on CBS Radio’s “Park Sung-tae’s News Show.” Captured from the program’s YouTube channel

(TNND) —A new report from Gallup shows Americans’ use of GLP-1 drugs for weight loss has nearly quadrupled in the last two years

‘America’s Got Talent’ judge Heidi Klum tells Fox News Digital it’s ‘no big deal’ that she went topless during her vacation

Medifast Inc (ISIN US58470S1024) is a US-based nutrition and weight-loss company whose shares trade in the United States, giving retail investors direct exposure to the evolving weight-management and wellness market. The company has been adjusting its strategy as demand patterns shift across the industry and as consumers increasingly look for structured programs that combine nutrition,…

The cross-border network distributed more than 200,000 counterfeit condoms across the continent

When it comes to most things in life, it takes a village, and the habits that shape your health are often no exception. I start almost every morning with warm sencha green tea, even when my body is screaming at me for coffee, because that’s how my mom has always started her mornings. And although…

A next-generation weight-loss drug being tested by Eli Lilly is showing major results in clinical trials, including a possible added benefit for people with knee osteoarthritis

With the proliferation of telehealth websites, Yale researchers were curious how much oversight is required to get GLP-1 weight-loss drugs. To find out, one of the researchers, posing as an overweight man, started shopping around

Conexeu Sciences Inc. (NASDAQ: CNXU) completed the P.R.O.O.F phase of its CXU preclinical program, the evidence base behind a focused first move into a roughly $11 billion medical aesthetics injectable market, an opening the company argues today’s tools were never built to reach